Top 300 Pharmacy Drug Cards 18

A fast, fun, and effective way to learn essential information about the top 300 drugs

Everything you need to know about the top 300 drugs in one easy-to-carry resource. Each card includes:
• Generic and common name
• Class
• Dosage Forms
• Approved Dose and Indications
• Off-Label Use
• Contraindications
• Adverse Reactions
• Drug Interactions
• Monitoring Parameters
• Medication Safety Issues and Black Box Warnings
• Strong focus on patient safety

Great for NAPLEX® and course review!

No internet connection needed to view the full app. It is all ready for super quick image and information retrieval. This app is optimized for whatever size device you are using, either phone or tablet.

Each card also features a photograph as well as important drug information. You can also search the entire text with our lightning fast search tool. The search tool shows you suggested words as you type so it is quick and helps with spelling issues. You can also add notes to each drug card, as well as bookmark drug cards as Know and Don't Know to help with studying. You also have the ability to change the text size for easier reading.

Check out www.usatinemedia.com to learn more and watch a video demo of this app.


This interactive app is based on the full content of McGraw-Hill's 2018/2019 Top 300 Pharmacy Drug Cards by McGraw-Hill Education.

Editors:
Jill M. Kolesar, PharmD, MS, BCPS, FCCP
Professor, College of Pharmacy
Director, Early Phase Clinical Trials Center
Co-Director, Molecular Tumor Board
Markey Cancer Center
University of Kentucky, Lexington, Kentucky

Lee C. Vermeulen, BSPharm, MS, FCCP, FFIP
Professor of Medicine and Pharmacy
Director, Office for Value and Innovation in Healthcare Delivery, UK HealthCare
University of Kentucky, Lexington, Kentucky


Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population.


Developed by Usatine Media, LLC
Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health Science Center San Antonio
Peter Erickson, Co-President, Lead Software Developer